Skip to Content

Join the 'Multaq' group to help and get support from people like you.

Multaq News

Statins Often Interact With Other Heart Drugs

Posted 17 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Cholesterol-lowering statins can interact with other drugs prescribed for heart disease. But there are ways to navigate the problem, according to new recommendations from the American Heart Association. Statins are among the mostly widely prescribed drugs in the United States. Roughly one-quarter of Americans age 40 and up are on a statin, according to a 2014 study by the ...

Heart Drug Digoxin May Not Be Best for Some Heart Patients

Posted 5 May 2015 by Drugs.com

TUESDAY, May 5, 2015 – Taking the heart drug digoxin may increase the risk of premature death in patients with an irregular heartbeat and in those suffering from heart failure, German researchers report. In the review of published studies on the subject, patients treated with digoxin had a 21 percent increased risk of early death overall from any cause, compared with patients not taking the ...

Health Tip: When Food and Drugs Interact

Posted 27 Feb 2014 by Drugs.com

-- When food and drinks interact with medication, the medication may not work sufficiently or the drug can become too powerful as the body has trouble handling it properly. The Academy of Nutrition and Dietetics mentions these common examples of food and drug interaction: Grapefruit juice interacts with several drugs and may affect the way the body metabolizes medication. Drugs that may interact ...

FDA Medwatch Alert: Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events

Posted 19 Dec 2011 by Drugs.com

[UPDATED 12/19/2011] FDA completed a safety review of Multaq (dronedarone). This review showed that Multaq increased the risk of serious cardiovascular events, including death, when used by patients in permanent atrial fibrillation (AF). The review was based on data from two clinical trials, PALLAS and ATHENA. FDA is providing new information and recommendations for the use of Multaq to manage ...

FDA Medwatch Alert: Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events

Posted 22 Jul 2011 by Drugs.com

ISSUE: FDA notified healthcare professionals that it is reviewing data from a clinical trial that evaluated the effects of the antiarrhythmic drug Multaq (dronedarone) in patients with permanent atrial fibrillation. The study was stopped early after the data monitoring committee found a two-fold increase in death, as well as two-fold increases in stroke and hospitalization for heart failure in ...

Ask a Question

Further Information

Related Condition Support Groups

Atrial Fibrillation, Atrial Flutter

Multaq Patient Information at Drugs.com